Canakinumab (Ilaris)

canakinumab · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Canakinumab (Ilaris), covering 2025-06-17 to 2025-06-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung Cancer [Phase 2]